Regorafenib in metastatic colorectal cancer: Optimal dosing and patient selection recommendations

Axel Grothey

Research output: Contribution to journal › Comment/debate › peer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Regorafenib in metastatic colorectal cancer: Optimal dosing and patient selection recommendations'. Together they form a unique fingerprint.